Posted On: 09/02/2014 6:29:02 PM
Post# of 30066
Re: brickbybrick #5351
LymPro Market guidance
"The market opportunity for the test was noted to be $150 million, and GC said they had a good chance of capturing a substantial portion of that market"
Everyone can glean what they want. We all want a solid number, so in my head I'm using 100 million. Half of the 150 is 75 mil. substantial>Half. I doubt we will capture all of the 150 million market.
Therefore, my reasoning leads to $100 million in revenue for LymPro for AMBS in 2015.
This should increase substantially in the following years
"The market opportunity for the test was noted to be $150 million, and GC said they had a good chance of capturing a substantial portion of that market"
Everyone can glean what they want. We all want a solid number, so in my head I'm using 100 million. Half of the 150 is 75 mil. substantial>Half. I doubt we will capture all of the 150 million market.
Therefore, my reasoning leads to $100 million in revenue for LymPro for AMBS in 2015.
This should increase substantially in the following years
(0)
(0)
